Helgi Library
Company

Merck Czech Republic

Pharmaceutical · Czechia

Available Indicators

85 indicators for Merck Czech Republic. Each opens with a chart and the full value history.

Cost Per Employee (Local Currency) (CZK per month)yearly 2002-2017Net Profit (CZK mil)yearly 2002-2017ROE (%)yearly 2002-2017Employeesyearly 2001-2017ROA (%)yearly 2002-2017Total Assets (CZK mil)yearly 2002-2017Cost Per Employee (USD per month)yearly 2002-2017Dividends (CZK mil)yearly 2001-2006Pre-Tax Profit (CZK mil)yearly 2002-2017Shareholders' Equity (CZK mil)yearly 2002-2017Staff Cost (As % Of Total Cost) (%)yearly 2002-2017Capital Employed (CZK mil)yearly 2002-2017Capital Expenditures (CZK mil)yearly 2016-2017Capital Expenditures (As % of Sales) (%)yearly 2016-2017Cash & Cash Equivalents (CZK mil)yearly 2002-2017Cash Conversion Cycle (days)yearly 2002-2017Cash Earnings (CZK mil)yearly 2002-2017Change in Working Capital (CZK mil)yearly 2016-2017Cost of Financing (%)yearly 2003-2015Cost of Goods & Services (CZK mil)yearly 2002-2017Current Assets (CZK mil)yearly 2002-2017Current Liabilities (CZK mil)yearly 2002-2017Days Payable Outstanding (days)yearly 2002-2017Days Sales Of Inventory (days)yearly 2002-2017Days Sales Outstanding (days)yearly 2002-2017Deferred Tax Liabilities (CZK mil)yearly 2002-2017Depreciation (CZK mil)yearly 2002-2017EBIT (CZK mil)yearly 2002-2017EBITDA (CZK mil)yearly 2002-2017EBITDA Growth (%)yearly 2003-2017EBITDA Margin (%)yearly 2002-2017EBIT Growth (%)yearly 2003-2017EBIT Margin (%)yearly 2002-2017Effective Tax Rate (%)yearly 2002-2017Equity And Liabilities (CZK mil)yearly 2002-2017Equity (As % Of Assets)yearly 2002-2017Extraordinary Cost (CZK mil)yearly 2002-2017Financing Cost (CZK mil)yearly 2002-2017Free Cash Flow (CZK mil)yearly 2016-2017Gross Margin (%)yearly 2002-2017Gross Profit (CZK mil)yearly 2002-2017Intangible Assets (CZK mil)yearly 2002-2017Inventories (CZK mil)yearly 2002-2017Issuance Of Debt (CZK mil)yearly 2016-2017Liabilities (CZK mil)yearly 2002-2017Long-Term Debt (CZK mil)yearly 2002-2017Minorities (CZK mil)yearly 2002-2017Net Change In Cash (CZK mil)yearly 2016-2017Net Debt (CZK mil)yearly 2002-2017Net Debt/EBITDAyearly 2002-2017Net Debt/Equity (%)yearly 2002-2017Net Debt Growth (%)yearly 2003-2017Net Margin (%)yearly 2002-2017Net Profit Growth (%)yearly 2003-2017Non-Cash Items (CZK mil)yearly 2016-2017Non-Current Assets (CZK mil)yearly 2002-2017Non-Current Liabilities (CZK mil)yearly 2002-2017Of Which Minority Interest (CZK mil)yearly 2002-2017Operating Cost Growth (%)yearly 2003-2017Other Cost (CZK mil)yearly 2002-2017Other Investments (CZK mil)yearly 2016-2017Payout Ratio (%)yearly 2002-2006Pre-Tax Profit Growth (%)yearly 2003-2017Property, Plant & Equipment (CZK mil)yearly 2002-2017Provisions (CZK mil)yearly 2002-2017Receivables (CZK mil)yearly 2002-2017ROCE (%)yearly 2003-2017ROTEyearly 2003-2017Sales (CZK mil)yearly 2002-2017Sales from Chemistry (CZK mil)yearly 2001-2017Sales from Pharmacy (CZK mil)yearly 2001-2017Sales From Services (CZK mil)yearly 2001-2017Shareholders' Equity Growth (%)yearly 2003-2017Short-Term Debt (CZK mil)yearly 2002-2017Staff Cost (CZK mil)yearly 2002-2017Tax (CZK mil)yearly 2002-2017Total Asset Growth (%)yearly 2003-2017Total Cash From Financing (CZK mil)yearly 2016-2017Total Cash From Investing (CZK mil)yearly 2016-2017Total Cash From Operations (CZK mil)yearly 2016-2017Total Debt (CZK mil)yearly 2002-2017Total Debt Growth (%)yearly 2003-2015Total Revenue Growth (%)yearly 2003-2017Trade Payables (CZK mil)yearly 2002-2017Working Capital (CZK mil)yearly 2002-2017
Whole Company
$19.99 one-off
  • ✓ All 85 indicators of Merck Czech Republic
  • ✓ Full history, all frequencies
  • ✓ Excel download
  • ✓ Source & methodology included
Download Excel